Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Veteran NBC newsman Brokaw says his cancer is in remission
- New York farmers lament lost opportunity for natural gas riches with fracking ban
- Tent city sprouts in shadow of downtown Detroit
- NYPD: Cop ambush killer told passers-by to watch
- Arizona immigrants OK’d to apply for driver’s licenses
- New York City subways slowly upgrading from 1930s-era technology
- Coal mines near record low in worker deaths
- Florida officer slain; 1 charged
- Nativity scene placed by Satanic display at Michigan Capitol
- Government survey: More teens trying out e-cigarettes than real thing
- WikiLeaks releases purported CIA documents on operatives’ travel